Supplement
Beta Glucan
Discover the science-backed potential of beta glucan as an adjunct in cancer therapy. This post delves into the latest research
Click 
Chlorella, a genus of unicellular green algae, has attracted considerable attention for its potential anti-cancer properties. Research indicates that Chlorella may exert anti-cancer effects through multiple mechanisms, including the induction of apoptosis (programmed cell death), inhibition of tumour proliferation, enhancement of immune responses, and reduction of metastasis and angiogenesis.
Induction of Apoptosis:
Chlorella vulgaris has been shown to induce apoptosis in cancer cells, particularly in liver cancer (HepG2) cell lines. This effect is mediated by upregulating pro-apoptotic proteins such as p53, Bax, and caspase-3, while downregulating the anti-apoptotic protein Bcl-2. This shift promotes DNA damage and cell death in cancer cells, with a significantly higher apoptotic rate observed in cancer cells compared to normal cells12.
Antioxidant Activity:
The antioxidant properties of Chlorella help reduce oxidative stress, which is a known contributor to cancer development. By decreasing lipid peroxidation and scavenging free radicals, Chlorella may prevent the initiation and progression of tumours23.
Immune System Enhancement:
Chlorella stimulates the production and maturation of granulocytes and macrophages, and enhances natural killer (NK) cell activity. It also increases the production of immune-modulating cytokines such as IL-2, IFN-γ, and TNF-α, which can contribute to the destruction of tumour cells and support the body’s natural defences against cancer2.
Inhibition of Metastasis and Angiogenesis:
Chlorella extracts have been shown to suppress the expression of matrix metalloproteinases (MMP-1, MMP-2, and MMP-9), enzymes involved in the degradation of the extracellular matrix and tumour metastasis. Additionally, Chlorella can downregulate vascular endothelial growth factor receptor-2 (VEGFR2), thereby inhibiting the formation of new blood vessels (angiogenesis) necessary for tumour growth and spread2.
Synergy with Conventional Therapies:
Chlorella glycoproteins have been observed to reduce the side effects of chemotherapy drugs such as 5-fluorouracil without diminishing their anti-tumour efficacy, making Chlorella a promising adjunct in cancer therapy2.
| Cancer Type | Chlorella Species/Extract | Observed Effects |
|---|---|---|
| Liver (HepG2) | C. vulgaris | Induced apoptosis, reduced tumour size, downregulated tumour markers, reduced lipid peroxidation12 |
| Breast | C. pyrenoidosa, C. vulgaris | Suppressed tumour frequency and size, increased apoptosis, inhibited metastasis2 |
| Colon | C. ellipsoidea, C. vulgaris | Induced apoptosis in colon cancer cells, cytotoxic effects via carotenoids2 |
| Lung (NSCLC) | C. vulgaris, C. sorokiniana | Inhibited proliferation and migration, reduced tumour growth in vivo23 |
Chlorella contains a variety of bioactive compounds, including carotenoids (e.g., violaxanthin), polyphenols, flavonoids, and unique long-chain hydrocarbons. For example, Chlorella sorokiniana extracts have demonstrated significant cytotoxicity against lung cancer cell lines (A549) with an IC50 value of 41.49 µg/ml, suggesting potent anti-cancer activity at relatively low concentrations3.
Chlorella demonstrates multiple anti-cancer mechanisms—inducing apoptosis, enhancing immune function, inhibiting metastasis, and providing antioxidant protection. While its effects may not be as potent as conventional chemotherapy, studies suggest that Chlorella could serve as a supportive or adjunctive therapy, potentially improving outcomes and reducing side effects for cancer patients2. Further clinical research is warranted to fully establish its efficacy and safety profile in humans.
There is no single universally established dosage for Chlorella, but a range of safe and commonly used dosages has been identified in both clinical studies and expert guidelines.
Most studies and supplement manufacturers recommend a daily intake of 3–10 grams of Chlorella, taken by mouth, often for periods of 2–3 months124589.
Some sources suggest that doses up to 10–15 grams per day appear to be safe for adults, though higher doses have not been extensively tested26.
For general health support, a common dosage is 2–5 grams per day511.
For specific conditions or intensive detoxification, doses as high as 20 grams per day have been used under medical supervision, but such high intakes are not typical for most users6.
It is generally advised to start with a lower dose (e.g., 1 gram per day) and gradually increase to the desired level to minimise potential digestive side effects such as bloating or cramping458.
Individual tolerance and health status should guide dose adjustment, and it is advisable to monitor your body’s response58.
Duration of Use
Chlorella is often taken daily, either year-round or in courses of 2–4 months, with breaks in between158.
Children
For children, the recommended dosage is typically 1 gram per 20 kg of body weight, adjusted proportionally58.
Product Variation
The nutritional content of Chlorella supplements can vary depending on the species, cultivation, and processing methods. Always follow the manufacturer’s instructions and consult a healthcare provider for personalised advice15.
| Population | Common Daily Dosage | Notes |
|---|---|---|
| Adults | 3–10 grams | Safe up to 10–15 grams in some studies |
| Children | 1g per 20kg body wt | Adjust for weight |
| Intensive use | Up to 20 grams | Under medical supervision only |
While there is no official UK or international guideline for Chlorella dosage, 3–10 grams per day is widely considered safe for most adults. Start low and increase gradually, and always consult a healthcare professional, especially if you have underlying health conditions or are taking other medications.
Breast Cancer, Cervical Cancer, Colon Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Skin Cancer (including Melanoma), Stomach Cancer
Chlorella is generally considered safe and well tolerated when taken by mouth, even at higher doses used in cancer-related protocols (up to 20 grams per day in some studies)45. However, it can cause side effects, especially during the first week or two of use.
The most frequently reported side effects include:
These digestive symptoms are usually mild and tend to resolve as the body adapts to supplementation25.
Skin sensitivity to sunlight (photosensitivity): Chlorella can make the skin more sensitive to sunlight, increasing the risk of sunburn. It is advisable to use sunblock, especially for those with lighter skin145.
Allergic reactions: Rare but potentially serious allergic reactions have been reported, including asthma, breathing difficulties, and anaphylaxis. Individuals with known allergies to moulds or iodine should exercise caution, as Chlorella can contain these allergens12456.
Respiratory issues: Asthma and other breathing problems have occurred in some users45.
Potential interactions: Chlorella may interact with blood thinners (such as warfarin) and immunosuppressant medications, so medical advice should be sought if you are taking these drugs46.
Special Precautions
Immunocompromised individuals: Those with weakened immune systems should use caution, as Chlorella might promote the growth of “bad” bacteria in the gut1.
Pregnancy and breastfeeding: Chlorella appears to be possibly safe when used during pregnancy for up to 28 weeks, but there is insufficient information regarding its safety during breastfeeding. It is best to consult a healthcare professional before use16.
Studies involving cancer patients have used doses up to 20 grams per day, often in divided doses and sometimes alongside liquid extracts4. At these higher doses, the same side effects as above have been observed, but no new or severe adverse reactions have been consistently reported in the literature43.
| Side Effect | Frequency/Notes |
|---|---|
| Diarrhoea, nausea, gas | Common, especially at start; usually mild and transient |
| Green stools | Common, harmless |
| Stomach cramping | Common, especially early on |
| Skin photosensitivity | Occasional; use sunblock |
| Allergic reactions | Rare but possible; includes asthma, anaphylaxis |
| Respiratory issues | Rare |
| Drug interactions | Possible with blood thinners, immunosuppressants |
Chlorella is generally safe at therapeutic doses used in cancer protocols, with most side effects being mild and transient. However, rare but serious allergic reactions can occur, and those with allergies, on certain medications, or with specific health conditions should consult a healthcare provider before starting supplementation.
Chlorella has been explored in combination with various therapies to enhance its anti-cancer effects and reduce the side effects of conventional treatments.
Enhancing Immunity and Reducing Side Effects: Chlorella glycoproteins have been shown to enhance immunity and reduce the side effects of chemotherapy drugs like 5-fluorouracil (5-FU) without diminishing their anti-tumour efficacy17. This suggests that Chlorella could be used as an adjunct to improve the tolerance and effectiveness of chemotherapy.
Protection Against Cisplatin Toxicity: Chlorella sorokiniana extract has been found to protect against cisplatin-induced bone marrow toxicity, potentially supporting its use alongside chemotherapy to mitigate adverse effects6.
Oxygen Production for Hypoxic Tumours: Chlorella’s ability to produce oxygen through photosynthesis has been leveraged to alleviate tumour hypoxia, enhancing the effectiveness of photodynamic therapy (PDT). This approach involves using Chlorella as an oxygenator to improve oxygen availability around photosensitizers, thereby increasing the efficacy of PDT1.
Enhanced Immune Response: Chlorella extracts have been shown to stimulate the immune system by increasing the production of cytokines such as IL-2, IFN-γ, and TNF-α, which can enhance the effects of immunotherapy7. This suggests potential benefits when used in combination with immune-modulating therapies.
Synergistic Effects with Young Green Barley: Studies have demonstrated that combining Chlorella with young green barley extracts can enhance chemopreventive properties against colon cancer, showing stronger antiproliferative effects than either extract alone5.
| Combination Therapy | Effects and Benefits |
|---|---|
| Chemotherapy (5-FU, Cisplatin) | Enhances immunity, reduces side effects, protects against bone marrow toxicity |
| Photodynamic Therapy (PDT) | Alleviates tumour hypoxia, improves oxygen availability for enhanced PDT efficacy |
| Immunotherapy | Stimulates immune response, potentially enhancing immunotherapy effects |
| Young Green Barley Extracts | Synergistic antiproliferative effects against colon cancer, enhancing chemoprevention |
Chlorella has been tested in combination with various therapies, showing promise in enhancing treatment efficacy and reducing side effects. Its potential as an adjunct to conventional cancer treatments warrants further clinical investigation.
US National Library of Medicine research on Chlorella
Europe PMC research on Chlorella
Pubmed research on Chlorella
A randomised, controlled study specifically investigated the quality of life (QOL) impact of Chlorella supplementation in breast cancer patients at therapeutic doses (granules or extract daily for one month).
The key findings were:
Improved Breast Cancer-Related QOL:
Patients taking Chlorella granules experienced a statistically significant improvement in the breast cancer subscale of the Functional Assessment of Cancer Therapy-Breast (FACT-B) score compared to baseline. This subscale measures symptoms and psychological aspects related to breast cancer and its treatment, such as swelling, tenderness, hair loss, and emotional concerns about illness and family1.
Reduction in Fatigue and Skin Complaints:
Half of the patients in the Chlorella extract group reported positive effects, notably reduced fatigue and improvements in dry skin, compared to the control group1.
Physical and Emotional Well-being:
While not all subscales reached statistical significance, the Chlorella granule group showed trends toward improvement in physical and emotional well-being, with some items (e.g., less bother from arm swelling and hair loss, reduced worry about family risk and stress) showing notable increases1.
Antioxidant and Immune Support:
Chlorella’s antioxidant compounds can help reduce oxidative damage from cancer treatments, potentially lowering side effects and supporting overall health and recovery2.
Immune Modulation:
Supplementation has been shown to enhance immune cell function, which may contribute to better resilience during and after therapy12.
Potential for Reduced Side Effects:
Early research suggests Chlorella may help patients better tolerate chemotherapy and radiation, possibly by boosting the immune system and reducing therapy-induced fatigue and gastrointestinal symptoms3.
Summary Table: Quality of Life Effects
| QOL Aspect | Observed Impact with Chlorella (Therapeutic Dose) |
|---|---|
| Fatigue | Reduced (notably with extract) |
| Skin dryness | Improved (extract group) |
| Emotional well-being | Improved (granule group, some subscale items) |
| Physical symptoms (e.g. swelling) | Improved (granule group, arm swelling/tenderness) |
| Tolerance of therapy | Possibly improved (less fatigue, better immune status) |
| Side effects | Mostly mild and transient; rare serious reactions |
At therapeutic levels, Chlorella supplementation can modestly improve quality of life for cancer patients—especially those with breast cancer—by reducing fatigue, improving skin condition, and lessening some physical and emotional symptoms associated with cancer and its treatment. Benefits are most pronounced in vitality and specific symptoms, with good overall tolerability for most users.
We’ve done our best to include as much information as possible for this supplement.
If you have any other questions, please send us a message or join our Skool Group and ask our knowledgeable and friendly community.
Chlorella is readily accessible in the UK as a dietary supplement and can be purchased from health food stores, pharmacies, and online retailers without a prescription.
There is currently no universally established patient demographic that has been formally defined as most likely to benefit from Chlorella in cancer therapy. However, available research and clinical studies suggest certain groups may experience particular advantages:
The most robust clinical evidence comes from studies involving women with breast cancer, typically aged around 50, living at home and not hospitalised.
In a randomised study, breast cancer patients taking Chlorella granules or extract reported improved quality of life, reduced fatigue, and better skin condition compared to controls1.
Chlorella supplementation also improved immune cell function in these patients, which may support recovery and resilience during or after conventional cancer treatment1.
Chlorella has shown potential in reducing some side effects of chemotherapy, such as myelosuppression, and in accelerating the recovery of blood cell counts45.
It may also help protect against bone marrow toxicity from drugs like cisplatin and support overall antioxidant status during treatment5.
Chlorella appears to enhance immune function by increasing the activity of natural killer (NK) cells and boosting cytokine production, which could be beneficial for those with compromised immunity due to cancer or its treatment43.
Preclinical and animal studies indicate that Chlorella may be particularly effective against:
Some extracts, such as those from Chlorella sorokiniana, have shown stronger effects on certain cancer cell lines (e.g., lung adenocarcinoma A549 cells)5.
Many cancer patients, particularly women with breast cancer, report using natural products and CAM approaches alongside conventional treatments1.
Summary Table: Patient Groups with Observed or Potential Benefit
| Demographic/Group | Evidence/Notes |
|---|---|
| Female breast cancer patients, ~50 years old | Improved quality of life, reduced fatigue, immune benefits1 |
| Patients undergoing chemotherapy/radiotherapy | Reduced side effects, improved blood counts, antioxidant support45 |
| Immunocompromised cancer patients | Enhanced NK cell activity, cytokine production43 |
| Patients with liver, breast, colon, or lung cancer | Most preclinical and some clinical evidence of efficacy45 |
| CAM users | Widely used as a supplement for general health and adjunctive support1 |
While a precise patient demographic has not been officially established, women with breast cancer (around age 50), patients undergoing chemotherapy or radiotherapy, and those with liver, colon, or lung cancers appear most likely to benefit from Chlorella supplementation, based on current evidence. The greatest benefits are seen in quality of life, immune support, and reduction of treatment side effects. As always, use should be individualised and discussed with a healthcare provider.
Currently, there is no specific evidence of resistance markers identified in cancer cells or patients that would affect the efficacy of Chlorella as an anti-cancer agent. The mechanisms by which Chlorella exerts its anti-cancer effects include inducing apoptosis, enhancing immune function, and inhibiting tumour proliferation, but these processes do not appear to be influenced by known resistance markers like those seen with conventional chemotherapies (e.g., drug efflux pumps, mutations in drug targets).
Key Findings:
Chlorella’s anti-cancer effects are primarily attributed to its bioactive compounds, such as polysaccharides, glycoproteins, and polyphenols, which induce apoptosis and modulate immune responses15.
There is no documented evidence of resistance mechanisms (e.g., genetic mutations, epigenetic changes) that specifically counteract Chlorella’s anti-cancer properties.
The potential for resistance development is generally lower with natural compounds compared to targeted therapies or conventional chemotherapies, as they often act through multiple pathways.
Conclusion
While resistance markers are a significant concern in cancer therapy, particularly with targeted and conventional chemotherapies, there is currently no evidence that such markers specifically affect the efficacy of Chlorella in cancer treatment. Further research could explore potential interactions or resistance mechanisms, but as of April 2025, none have been identified.
Pre-clinical studies on Chlorella’s anti-cancer effects have primarily focused on in vitro (cell culture) and in vivo (animal) models, demonstrating efficacy across multiple cancer types. Below is a summary of key findings:
Liver Cancer (HepG2)
Breast Cancer (MCF-7)
Colon Cancer (HT-29, HCT116)
Lung Cancer (A549, H1299, H1437)
Cervical (HeLa) and Melanoma (A375)
Species: Chlorella sorokiniana
Outcome: Reduced viability at concentrations >100 µg/ml6.
Liver Cancer (Chemically Induced in Rats)
Breast Cancer (N-methyl-N-nitrosourea-Induced in Rats)
Ehrlich Ascites Carcinoma (Mice)
Apoptosis Induction: Via modulation of pro- and anti-apoptotic proteins (e.g., Bax/Bcl-2, caspase activation).
Immune System Enhancement: Increased NK cell activity and cytokine production.
Anti-Angiogenesis: Suppression of VEGF and matrix metalloproteinases (MMPs).
Oxidative Stress Reduction: High antioxidant activity mitigating lipid peroxidation.
Pre-clinical trials demonstrate Chlorella’s broad-spectrum anti-cancer potential, particularly in liver, breast, colon, and lung cancers. While mechanisms like apoptosis induction and immune modulation are consistent across studies, most evidence remains limited to laboratory and animal models. Human clinical trials are needed to validate these findings.
Based on currently available information, Chlorella is not part of any registered or ongoing clinical trials specifically targeting cancer as of April 2025. The clinical trials involving Chlorella that are publicly documented focus on other conditions such as type 2 diabetes, fibromyalgia, hypertension, and ulcerative colitis, rather than cancer134.
No studies or clinical trial registries indicate that Chlorella is being tested in any phase (0–4) of cancer clinical trials at this time. The phases of clinical trials—ranging from early safety and dosing studies (phase 1) to large-scale efficacy and safety comparisons (phase 3)—are well established for cancer treatments, but Chlorella does not currently appear in these for oncology indications25.
Summary:
Chlorella is not currently in any phase of clinical trials for cancer.
Existing clinical research with Chlorella has focused on non-cancer conditions.
If new trials are launched in the future, they would be listed in clinical trial registries and cancer research databases. For now, its anti-cancer potential remains supported by laboratory and animal studies, rather than human clinical trials.
The majority of studies are in preclinical or early clinical phases. See more
No specific genetic markers in humans or cancer patients have been identified that affect the efficacy of Chlorella as an anti-cancer therapy. The available research and genetic studies on Chlorella focus primarily on the genetics of the Chlorella species itself—such as identifying stable reference genes for gene expression studies, genetic diversity among Chlorella strains, and genetic engineering of Chlorella for improved industrial or environmental performance—not on patient or tumour genetic markers that would predict therapeutic response456.
While some studies have mapped gene families and metabolic pathways in various Chlorella strains to explain their adaptability and performance in different environments, these findings relate to the biology of the algae, not to personalised medicine or pharmacogenomics in human patients5. No clinical or preclinical evidence currently links human genetic variants or tumour genotypes to altered efficacy of Chlorella supplementation in cancer therapy.
Summary:
No human or cancer genetic markers are known to influence Chlorella’s anti-cancer efficacy.
Genetic research on Chlorella is focused on the organism itself, not on patient stratification or precision oncology456.
If such markers are identified in the future, they would likely be reported in clinical trial or pharmacogenomics literature, but as of now, none have been established.
Discover the science-backed potential of beta glucan as an adjunct in cancer therapy. This post delves into the latest research
Explore the emerging world of hydrogen gas (H₂), also known as Brown Gas, and its remarkable potential as an adjunct
Explore the latest scientific insights into vitamin K2 and its promising role in cancer therapy. In this comprehensive blog post,
Website designed in collaboration with Simon Lown for Metabolic Therapy Ltd
Apoptosis, or programmed cell death, is a natural process where cells self-destruct when they are damaged or no longer needed. This is crucial for maintaining healthy tissues and preventing diseases like cancer.
Drugs and supplements that induce apoptosis help eliminate cancerous cells by triggering this self-destruct mechanism, ensuring that harmful cells are removed without damaging surrounding healthy tissue.
Understanding and harnessing apoptosis is vital in the fight against cancer, as it targets the root cause of the disease at the cellular level.
Cell proliferation is the process by which cells grow and divide to produce more cells. While this is essential for growth and healing, uncontrolled cell proliferation can lead to cancer.
Drugs and supplements that inhibit cell proliferation help prevent the rapid multiplication of cancerous cells, slowing down or stopping the progression of the disease.
By targeting the mechanisms that drive cell division, these treatments play a vital role in controlling and potentially eradicating cancer.
Cancer cells often hijack specific biological pathways to grow and spread. Drugs and supplements that target these pathways can disrupt the cancer cell’s ability to survive and multiply.
By focusing on the unique mechanisms that cancer cells use, these treatments can be more effective and cause fewer side effects compared to traditional therapies.
Targeting specific pathways is a key strategy in precision medicine, offering a tailored approach to combat cancer at its core.
Angiogenesis is the process by which new blood vessels form, supplying nutrients and oxygen to tissues. Cancer cells exploit this process to fuel their growth and spread.
Drugs and supplements that inhibit angiogenesis can effectively starve cancer cells by blocking the formation of these new blood vessels.
By cutting off the supply lines that tumors rely on, angiogenesis inhibitors play a crucial role in controlling and potentially shrinking cancerous growths.
Immunotherapy harnesses the power of the body’s immune system to combat cancer. By boosting or restoring the immune system’s natural ability to detect and destroy cancer cells, immunotherapy offers a targeted and effective approach to treatment.
Drugs and supplements that support immunotherapy can enhance the immune response, making it more efficient at identifying and attacking cancer cells.
This innovative approach not only helps in treating cancer but also reduces the risk of recurrence, providing a powerful tool in the fight against this disease.
Inflammation is the body’s natural response to injury or infection, but chronic inflammation can contribute to the development and progression of cancer.
Drugs and supplements with anti-inflammatory properties help reduce inflammation, thereby lowering the risk of cancer and other chronic diseases.
By targeting the inflammatory processes, these treatments can help maintain a healthier cellular environment and prevent the conditions that allow cancer to thrive.
